Virtu Financial’s Structure Therapeutics GPCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$354K Buy
+11,314
New +$531K 0.01% 686
2025
Q3
– Sell
-14,779
Closed -$307K – 1709
2025
Q2
$307K Buy
+14,779
New +$325K 0.02% 745
2024
Q3
– Sell
-10,034
Closed -$394K – 1562
2024
Q2
$394K Buy
10,034
+2,848
+40% +$117K 0.03% 513
2024
Q1
$308K Buy
+7,186
New +$303K 0.02% 607

Other funds holding GPCR

Virtu Financial's GPCR Position: Q3 2026 in Review

Virtu Financial opened a new position in Structure Therapeutics (GPCR) in Q3 2026: 11,314 shares worth $354K. The stake represents 0.01% of the portfolio and ranks #686 among its holdings. This is a return to the name: Virtu Financial previously reported a position in GPCR as recently as Q2 2025.

Virtu Financial first reported a position in GPCR in Q1 2024 and has held it in 4 quarters since. The position peaked at $394K in Q2 2024. 170 funds tracked by Wall St. Rank hold GPCR as of Q3 2026.

  • Virtu Financial held 11,314 shares of Structure Therapeutics worth $354K as of Q3 2026.
  • Structure Therapeutics was a new Virtu Financial position in Q3 2026.
  • Structure Therapeutics made up 0.01% of Virtu Financial's portfolio in Q3 2026, its #686 holding.
  • Virtu Financial first reported a position in Structure Therapeutics in Q1 2024 and has held it in 4 quarters since.
  • Virtu Financial's Structure Therapeutics position peaked at $394K in Q2 2024.
  • 170 funds tracked by Wall St. Rank held Structure Therapeutics as of Q3 2026.

Based on Virtu Financial's 13F filing for Q3 2026, filed 17 Nov 2026.